Marina Baretti, M.D.

Headshot of Marina Baretti
  • Assistant Professor of Oncology

Languages: English, French, Italian, Spanish




The Johns Hopkins Hospital

1650 Orleans Street
Room 186
Baltimore, MD 21287 map
Phone: 410-955-7893 | Fax: 410-955-0548



  • Assistant Professor of Oncology

Departments / Divisions

Centers & Institutes



  • MD; Universit? di Pisa Facolt? di Medicina e Chirurgia (2012)


  • Hematology and Medical Oncology; Johns Hopkins University School of Medicine (2021)
  • Medical Oncology; University degli Studi di Milano (2018)

Research & Publications

Research Summary

Dr. Marina Baretti is an oncologist in Baltimore, with an interest in translational research and a growing expertise in the care of gastrointestinal (GI) cancer patients, collaborating closely with laboratory-based researchers to move laboratory findings into patients and bring novel compounds to the clinic. Dr. Baretti has had outstanding success in developing a research program in hepatobiliary cancer at Johns Hopkins with her particular focus on studying the impact of epigenetic therapies as immune sensitizers. Dr. Baretti completed medical school at the University of Pisa, Italy, and she continued her medical training in Internal Medicine and Oncology at the University of Milan. She then performed a research postdoctoral fellowship and a fellowship in medical oncology at Johns Hopkins University School of Medicine. Dr. Baretti joined the Johns Hopkins faculty in 2021. Dr. Baretti was the recipient of the 2018 American Society of Clinical Oncology Young Investigator Award. Dr. Baretti was also awarded with the 2020 Career Development Award for the MD Anderson Cancer Center’s pancreatic cancer NCI Specialized Programs of Research Excellence (SPORE). This award is designed to promote cutting-edge approaches to improve the treatment of GI cancer and foster extended collaborations in critical areas of cancer research among laboratory and clinical scientists.

Clinical Trial Keywords

Liver Cancer; Bile Duct Cancer; Cholangiocarcinoma; Epigenetics; Immunotherapy

Activities & Honors


  • 2018 YIA Conquer Cancer Foundation for Cholangiocarcinoma, ASCO


  • American Society of Clinical Oncology (ASCO)
  • American Association for Cancer Research (AACR)
  • European Society for Medical Oncology (ESMO)

Patient Ratings & Comments

The Patient Rating score is an average of all responses to physician related questions on the national CG-CAHPS Medical Practice patient experience survey through Press Ganey. Responses are measured on a scale of 1 to 5, with 5 being the best score. Comments are also gathered from our CG-CAHPS Medical Practice Survey through Press Ganey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.

Is this you? Edit Profile
back to top button